Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes

Gauthier Glemarec,Jean-Louis Lacaze,Bastien Cabarrou,Richard Aziza,Eva Jouve,Slimane Zerdoud,Eleonora De Maio,Carole Massabeau,Maxime Loo,Vincent Esteyrie,Mony Ung,Florence Dalenc,Francoise Izar,Ciprian Chira

The Breast（2023）

引用 1|浏览4

暂无评分

摘要

•Outcomes of oligometastatic breast cancer (OMBC) cohort without cranial metastatases treated by local ablative treatment and systemic treatment.•Patients with LAT had more favorable PFS and OS compared to noLAT.•HR+ and HER + immunohistochemical (HIC) subtype had a more favorable OS and PFS compared to triple negatives patients, liver metastases had a worse PFS.

查看译文

关键词

Oligometastases,Breast cancer,Local ablative treatment,Standard of care,Systemic treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要